Earlier this week the Informed Medical Decisions Foundation medical editors, staff and esteemed guests took time out of their busy schedules to join us at our annual Boston-based Winter Medical Editors Meeting. A number of thought-provoking projects and developments were discussed and we’d like to highlight just a few for you. We were honored to have Victoria Shaffer, assistant professor at the University of Missouri and one of our grantees, present her fascinating work on the use of patient narratives in decision aids. Her current research is focused on developing a framework by which we can analyze and evaluate the content of patient narratives.
Angela Coulter, Foundation director of global initiatives and Al Mulley, Foundation co-founder both gave intriguing talks on global initiatives. Angela provided an update on shared decision making policy and implementation in the U.K. We were pleased to hear that our work to advance shared decision making through research, policy, clinical models and patient decision aids has influenced these developments abroad. Al gave an excellent talk about his work as a King’s Fund Fellow and the global impact of preference misdiagnosis.
We were also pleased to have Suzanne Brodney, a Foundation research associate, and Mary McGrae McDermott, a Foundation medical editor, debut our latest decision aid program, Treatment Choices for Peripheral Artery Disease. This program describes three types of treatments, including walking programs, medications and procedures (leg angioplasty and leg bypass surgery) that may help people with PAD.
And finally, a number of medical editors presented progress results of the TRENDS Study, a national survey of medical decisions funded by the Foundation. Kenrik Duru, Kathleen Fairfield and Richard Hoffman presented data on the epidemiology of medical decisions made in depression, geriatrics and cancer, respectively.
We’d like to thank all our staff, medical editors and colleagues for their hard work, whether it’s developing new decision aids like peripheral artery disease, keeping our existing decision aid portfolio up to date, forging and maintaining relationships to spread shared decision making around the world, or adding to our wealth of knowledge through research.